Ivan Antonevich, MD
Interventional Pain Medicine · New Hartford, NYNPI 1043256118
Payments from drug & device makers
Across 482 payments — averaging $26.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- AbbVie$2K
- Medtronic$2K
- Boston Scientific$2K
- Si-bone, Inc.$325
- Pfizer$240
- plus $2K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 118 | $3,470 |
| AbbVie(2 entities) | 110 | $2,355 |
| Medtronic(2 entities) | 53 | $2,286 |
| Boston Scientific | 95 | $2,229 |
| Si-bone, Inc. | 2 | $325 |
| Pfizer | 13 | $240 |
| Nevro Corp. | 8 | $165 |
| Ipsen Biopharmaceuticals, Inc | 8 | $155 |
| Globus Medical | 1 | $143 |
| Avanos Medical | 4 | $119 |
| GSK | 8 | $116 |
| Lundbeck LLC | 5 | $106 |
| Merz Pharmaceuticals, LLC | 5 | $101 |
| Stimwave Technologies Incorporated | 6 | $98 |
| Lilly USA, LLC | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 5 | $82 |
| Curonix LLC | 3 | $76 |
| Fidia Pharma USA Inc. | 4 | $75 |
| Averitas Pharma Inc. | 3 | $68 |
| Vertex | 2 | $54 |
| Merz North America, Inc. | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Almatica Pharma LLC | 2 | $41 |
| Johnson & Johnson | 2 | $37 |
| IBSA Pharma Inc. | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Novartis | 2 | $23 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
| Nalu Medical, Inc. | 1 | $18 |
| MDD US Operations, LLC | 1 | $15 |
| Bioventus LLC | 1 | $15 |
| Metacel Pharmaceuticals LLC | 1 | $12 |
| Foundation Fusion Solutions, LLC | 1 | $5 |
How this compares
$12,751 in reported general payments places this provider in the 75th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in New Hartford
- Sathish ModuguHartsdale$1.3M
- Neel MehtaNew York$655K
- Corey HunterNew York$571K
- Hemant KaliaRochester$234K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Jafar SiddiquiWilliamsville$70K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.